Chris Ronne counsels public and private companies, private equity, individual and institutional investors, and entrepreneurs in cross-border mergers and acquisitions, financings and strategic investments, and corporate governance matters. Chris has transactional experience across various industries, including biotechnology, life sciences and specialty pharmaceuticals, consumer products and retail, financial services and fintech, and technology and telecommunications. Before joining Morgan Lewis, Chris served as an attorney-advisor in the Division of Corporation Finance at the US Securities and Exchange Commission, and leverages that experience to advise clients with respect to the US federal securities laws and corporate governance matters.
While serving on the staff in the Division of Corporation Finance, Chris reviewed transactional and securities disclosures filed under the Securities Act of 1933, such as IPOs, follow-on offerings, spin-offs, and business combinations, as well as current and periodic reports by public companies filed pursuant to the Securities Exchange Act of 1934.
Listed, The Best Lawyers in America, Ones to Watch, Corporate Governance and Compliance Law, Seattle (2024, 2025)
Listed, The Best Lawyers in America, Ones to Watch, Corporate Governance and Compliance Law, Washington, DC (2023)